Samsung Biologics Announces Schedule for First Half 2026 Earnings Release
Samsung Biologics has announced that its first half 2026 earnings results will be disclosed on July 23, 2026.
The financial figures have not yet been released, and the scheduled date may change due to company circumstances.
[AI Summary]This disclosure is a procedural notice of the earnings release schedule, with no immediate impact on shareholder value confirmed. Investment decisions should be made after the actual results are released.
KOSPI Filing Information
Notice of Disclosure of Settlement Results (Informational Disclosure)